Sudeep Pharma IPO: Here's what you need to know
Sudeep Pharma is opening its IPO for subscription from November 21 to 25, aiming to raise ₹895 crore.
This includes ₹95 crore as a fresh issue and ₹800 crore from promoters selling their shares.
The price band is set at ₹563-593 per share, with a minimum bid of 25 shares.
What does Sudeep Pharma actually do?
The company makes specialty excipients and food-grade pharmaceutical ingredients using advanced tech like encapsulation and spray drying.
With clients in over 100 countries—including big names like Pfizer, Merck Group, and Danone—Sudeep runs a USFDA-approved facility in Gujarat that can produce over 72,000 metric tons annually.
Other key details
Most of the IPO funds will go toward buying new machinery for their Gujarat plant. The rest covers general corporate needs.
There's already some buzz: the gray market premium sits at about 22%, hinting at positive listing vibes.
ICICI Securities and IIFL Capital Services are managing the issue, while MUFG Intime India is handling registrations.